EA201892515A1 - Стероидные 6,7-бета-эпоксиды в качестве интермедиатов - Google Patents
Стероидные 6,7-бета-эпоксиды в качестве интермедиатовInfo
- Publication number
- EA201892515A1 EA201892515A1 EA201892515A EA201892515A EA201892515A1 EA 201892515 A1 EA201892515 A1 EA 201892515A1 EA 201892515 A EA201892515 A EA 201892515A EA 201892515 A EA201892515 A EA 201892515A EA 201892515 A1 EA201892515 A1 EA 201892515A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- epoxid
- intermediat
- steroid
- beta
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Настоящее изобретение относится к способу получения соединения общей формулы (Ia)в которой R, Y, Rи Rявляются такими, как указано в данной заявке. Изобретение также относится к некоторым соединениям per se. Эти соединения являются интермедиатами в синтезе синтетических желчных кислот.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1608779.3A GB201608779D0 (en) | 2016-05-18 | 2016-05-18 | Methods and compounds |
PCT/GB2017/051393 WO2017199039A1 (en) | 2016-05-18 | 2017-05-18 | Steroid 6.7.beta.-epoxides as chemical intermediates |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201892515A1 true EA201892515A1 (ru) | 2019-05-31 |
EA037742B1 EA037742B1 (ru) | 2021-05-17 |
Family
ID=56320631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201892515A EA037742B1 (ru) | 2016-05-18 | 2017-05-18 | Стероидные 6,7--эпоксиды в качестве интермедиатов |
Country Status (13)
Country | Link |
---|---|
US (1) | US20190153023A1 (ru) |
EP (1) | EP3458468B1 (ru) |
JP (1) | JP7034092B2 (ru) |
KR (1) | KR102509432B1 (ru) |
CN (1) | CN109415403A (ru) |
AU (1) | AU2017265925A1 (ru) |
BR (1) | BR112018073490A2 (ru) |
CA (1) | CA3024285A1 (ru) |
EA (1) | EA037742B1 (ru) |
ES (1) | ES2857869T3 (ru) |
GB (1) | GB201608779D0 (ru) |
MX (1) | MX2018014128A (ru) |
WO (1) | WO2017199039A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201608776D0 (en) * | 2016-05-18 | 2016-06-29 | Dextra Lab Ltd | Methods and compounds |
GB201608777D0 (en) | 2016-05-18 | 2016-06-29 | Dextra Lab Ltd | Compounds |
EP3431486A1 (en) * | 2017-07-18 | 2019-01-23 | Bionice, S.L.U. | Process and intermediates for the synthesis of obeticholic acid and derivatives thereof |
GB201812382D0 (en) | 2018-07-30 | 2018-09-12 | Nzp Uk Ltd | Compounds |
CN111072744B (zh) * | 2019-12-03 | 2021-09-14 | 江苏佳尔科药业集团股份有限公司 | 一种以ba为原料合成熊去氧胆酸的方法 |
CN113912661B (zh) * | 2021-11-11 | 2023-04-21 | 湖南科瑞生物制药股份有限公司 | 一种7-羟基甾体化合物的合成方法 |
CN114702542B (zh) * | 2022-05-11 | 2023-11-24 | 上海其正医药科技有限责任公司 | 一种25-羟基-7-去氢胆固醇的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20050912A1 (it) * | 2005-05-19 | 2006-11-20 | Erregierre Spa | Processo di preparazione di acidi 3-a-ya(b)-diidrossi-6-a(b)-alchil-5b-colanici |
JP2007210888A (ja) * | 2006-01-12 | 2007-08-23 | Mitsubishi Chemicals Corp | ステロイド化合物の製造方法 |
CN101374854A (zh) * | 2006-01-12 | 2009-02-25 | 三菱化学株式会社 | 甾类化合物的制备方法 |
KR102546748B1 (ko) * | 2014-11-19 | 2023-06-22 | 엔제트피 유케이 리미티드 | 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 6α-알킬-3,7-다이온 스테로이드 |
EP3221334B1 (en) * | 2014-11-19 | 2020-02-19 | Nzp Uk Limited | 6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators |
JP6724004B2 (ja) * | 2014-11-19 | 2020-07-15 | エヌゼットピー ユーケー リミテッド | ステロイドFXRモジュレーター製造のための中間体としての5β−6−アルキル−7−ヒドロキシ−3−オンステロイド |
PT3221331T (pt) * | 2014-11-19 | 2019-12-23 | Nzp Uk Ltd | Esteroides 6-alquil-7-hidroxi-4-en-3-ona como intermediários para a produção de moduladores de fxr esteroidais |
-
2016
- 2016-05-18 GB GBGB1608779.3A patent/GB201608779D0/en not_active Ceased
-
2017
- 2017-05-18 BR BR112018073490-0A patent/BR112018073490A2/pt unknown
- 2017-05-18 JP JP2018560585A patent/JP7034092B2/ja active Active
- 2017-05-18 EP EP17725744.1A patent/EP3458468B1/en active Active
- 2017-05-18 AU AU2017265925A patent/AU2017265925A1/en not_active Abandoned
- 2017-05-18 US US16/302,058 patent/US20190153023A1/en not_active Abandoned
- 2017-05-18 CN CN201780030408.5A patent/CN109415403A/zh not_active Withdrawn
- 2017-05-18 KR KR1020187035836A patent/KR102509432B1/ko active IP Right Grant
- 2017-05-18 EA EA201892515A patent/EA037742B1/ru unknown
- 2017-05-18 ES ES17725744T patent/ES2857869T3/es active Active
- 2017-05-18 CA CA3024285A patent/CA3024285A1/en active Pending
- 2017-05-18 WO PCT/GB2017/051393 patent/WO2017199039A1/en unknown
- 2017-05-18 MX MX2018014128A patent/MX2018014128A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
JP7034092B2 (ja) | 2022-03-11 |
GB201608779D0 (en) | 2016-06-29 |
WO2017199039A1 (en) | 2017-11-23 |
EA037742B1 (ru) | 2021-05-17 |
KR20190006187A (ko) | 2019-01-17 |
BR112018073490A2 (pt) | 2019-03-26 |
MX2018014128A (es) | 2019-04-29 |
ES2857869T3 (es) | 2021-09-29 |
EP3458468A1 (en) | 2019-03-27 |
CA3024285A1 (en) | 2017-11-23 |
AU2017265925A1 (en) | 2018-11-15 |
KR102509432B1 (ko) | 2023-03-13 |
US20190153023A1 (en) | 2019-05-23 |
CN109415403A (zh) | 2019-03-01 |
EP3458468B1 (en) | 2020-12-09 |
JP2019516717A (ja) | 2019-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201892515A1 (ru) | Стероидные 6,7-бета-эпоксиды в качестве интермедиатов | |
AR125320A2 (es) | Compuesto cristalino, método de preparación y composición que lo comprende | |
EA201890522A1 (ru) | Способ получения противогрибковых соединений | |
EA201792067A1 (ru) | Противогрибковые соединения и способы получения | |
SG10201809518QA (en) | Processes of preparing a jak1 inhibitor and new forms thereto | |
BR112016029333A2 (pt) | síntese de compostos de carbamoilpiridona policíclico | |
NZ726356A (en) | Processes for preparing antiviral compounds | |
EA201691794A1 (ru) | Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa) | |
SA518391776B1 (ar) | تخليق انتقائي مزدوج التجاسم لمشتقات الفوسفات | |
EA201790884A8 (ru) | 6-алкил-7-гидрокси-4-ен-3-оновые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr | |
EA201790885A1 (ru) | 6α-АЛКИЛ-6,7-ДИОНОВЫЕ СТЕРОИДЫ В КАЧЕСТВЕ ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ ДЛЯ ПОЛУЧЕНИЯ СТЕРОИДНЫХ МОДУЛЯТОРОВ FXR | |
EA201691648A1 (ru) | Способ получения противогрибковых соединений | |
EA201691649A1 (ru) | Способ получения противогрибковых соединений | |
EA201790879A1 (ru) | 6-альфа-алкил-3,7-дионовые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr | |
EA201691141A1 (ru) | Соединения против ccr6 | |
WO2017042828A3 (en) | Process for the preparation of selexipag | |
PH12019502093A1 (en) | Novel ester compounds, method for the production thereof and use thereof | |
EA201791058A1 (ru) | Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4) | |
EP3795578A3 (en) | Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof | |
CL2017000484A1 (es) | Compuestos de azetidiniloxifenilpirrolidina | |
WO2017064627A3 (en) | Process for preparation of eribulin and intermediates thereof | |
EA201892516A1 (ru) | Способ и интермедиаты для 6,7-альфа-эпоксидирования стероидных 4,6-диенов | |
CL2018002756A1 (es) | Un proceso mejorado para la preparación de tartrato de butorfanol. | |
IN2015CH01182A (ru) | ||
MX2019004024A (es) | Metodo para preparar acetofenonas sustituidas con ciclopropilo. |